Anastomosis Device Market Size, Share, and Industry Analysis By Product (Surgical Staplers (Powered, Manual), Surgical Sutures (Absorbable, Non Absorbable), and Others), By Application (Gynecology, Orthopedics, Cardiology, General Surgery, and Others), By End User (Hospitals & ASCs, Specialty Clinics, and Others), and by Regional Forecast till 2032

The global anastomosis device market is showing major growth due to the increasing shift toward minimally invasive surgeries, which decrease patient recovery time and postoperative complications. The anastomotic devices used colors to turn & modify the surgical instruments used to join two body structures, the vascular tubes or the segments of the intestines, with bypasses and gastrointestinal reconstructions.

• The United States Centers for Disease Control and Prevention indicates that in 2023, about 290,000 colorectal surgeries with stapler devices were being done in the United States, thus affirming that there is lot of use of these devices in gastrointestinal surgery.

Demand for precision anastomosis tools has been enhanced by robotic-assisted surgeries. There were over 9,400 gastrointestinal anastomosis procedures performed by robotic systems alone in Japan in 2023, indicating the growing trend of advanced surgical methods.

Anastomosis Device Market Driver

Anastomosis Device Market Growth Driven By Chronic Diseases

Over time, with chronic diseases becoming more widespread, such as cardiac, vascular, and gastrointestinal disorders, anastomosis devices have seen a rapid increase. These chronic diseases require a surgical intervention. Coronary bypass surgeries numbered almost 120,000 in 2023, affording a national testimonium by the U.S. National Center for Health Statistics on the centrality of anastomosis devices in cardiac care. Moreover, minimally invasive and robotic-assisted procedures are currently on their rise in popularity, spurring further adoption largely among the older population, which is at an increased risk for these ailments.

Anastomosis Device Market Restraint

High Costs, Complications, And Regulations Hinder Market Growth

Depending to high costs, advanced anastomosis devices can be inaccessible to lower-income health care settings. Furthermore, the risk of complications arising from anastomotic leaks can keep surgeons from using these devices more generally. When approval is questionable due to regions not accepting their standards, this can act as a blockade along the commercialization pathway since the standards would be divergent. These elements put together can stop consistent development for the end-user market.

Anastomosis Device Market Opportunity

Advancing Infrastructure And Innovation Drive Market Growth

Considering its burgeoning healthcare infrastructure, anastomotic devices find bigger markets in developing countries. With recent technological advancements, this equipment has become more practical and has recently emerged in the performance of complex procedures. Manufacturers are also increasingly entering into partnerships and mergers, extending their distribution channels around the world, thereby spurring further developments in products and services.

Segmentation

Key Insights

The report covers the following key insights:

• Prevalence of Chronic and Cardiovascular Diseases, By Key Countries
• Rising Healthcare Expenditure, By Key Countries
• Drivers, Restraints, Trends, and Opportunities
• Technological Advancements in Anastomosis Devices
• Business Strategies Adopted by Key Players
• Consolidated SWOT Analysis of Key Players
• Key Industry Developments (Mergers, Acquisitions, Partnerships)
• Overview: Regulatory Scenario

Analysis by Product

By product, the market is divided into surgical staplers (powered, manual), surgical sutures (absorbable, non absorbable), and others.

Powered staplers or surgical staplers are predicted to dominate the anastomosis device market since they have high precision, speed while reducing risks for complications during surgery. In lower resource settings and cost-sensitive scenarios, manual staplers are still widely used for procedures, but they are not experiencing growth as rapidly as powered staplers.

For surgical sutures, absorbable sutures will indeed increase significantly in oncological/inguinal surgeries owing to their deterioration, as those sutures do not need to be removed and do not injure or interfere with the patient care process as much. Non-absorbable sutures will still continue to be used in procedures that functionally require a longer duration of support of tissue in surgery, as non-absorbable sutures will continue to be used in more and more existing uses for non-absorbable suture will be replaced by the newer absorbable suture.

Analysis by Application

By application, the market is divided into gynecology, orthopedics, cardiology, general surgery, and others.

The anastomosis device market is forecast to be led by cardiology, thanks to the large volume of procedures related to coronary artery bypass grafting and cardiac surgeries requiring precise vessel connections. The growing frequency of cardiovascular conditions worldwide keeps the demand for this segment high.

The general surgery segment is expected to grow substantially, with anastomosis devices used frequently in operations such as gastrointestinal resection procedures increasingly common owing to lifestyle-related disorders. Advancements in minimally invasive techniques help this segment.

Analysis by End User

By end user, the market is divided into hospitals & ASCs, specialty clinics, and others.

Hospitals and ASCs have always dominated the market due to their high-level surgical techs, skilled personnel, and high volumes of complicated procedures; however, ASCs are getting more competitive mainly due to shorter recovery times and lower procedure upside.

Specialty clinics forecast considerable growth, as their adoption of minimally invasive technologies goes up and they operate in narrow surgical areas, so that they can provide targeted care whilst allowing for personalization that is very much in line with the use of anastomosis devices.

Regional Analysis

Based on geography, the market has been studied across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

To gain extensive insights into the market, Download for Customization

North America is likely to account for the largest share of the anastomosis device market, given that the region has advanced healthcare systems and large market participants. In this day and age, there is an increase in the incidence of chronic conditions, including cardiovascular and gastrointestinal disease, that will ultimately increase demand for surgical procedures across the region. Therefore, based on the rationale listed above, it may be premature to determine whether North America will continue to be a market leader for a few more years.

Europe will witness steady growth rates owing to its aging population requiring surgical treatments with anastomosis devices. The region has also shown increased improvement in government incentives to use advanced medical technologies. The mature medical ecosystem can contribute to market expansion globally.

With an increasingly higher budget for healthcare by both industrial and developing economies, it is expected to be the fastest-growing segment in the Asia-Pacific region. China and India will significantly contribute to the demand for anastomosis devices. In addition, the ever-growing acceptance of technology-intensified surgical procedures suggests even steeper projections of growth for the Asia Pacific region in demand for anastomosis devices.

Key Players Covered

The report includes the profiles of the following key players:

• Medtronic (Ireland)
• Johnson & Johnson Services, Inc. (U.S.)
• Getinge (Sweden)
• Smith + Nephew (U.K.)
• Braun SE (Germany)
• Coloplast A/S (Denmark)
• CONMED Corporation (U.S.)
• Intuitive Surgical (U.S.)

Key Industry Developments

• In January 2023, Lydus Medical received FDA 510(k) clearance for the Vesseal system - a microvascular anastomosis suture deployment device. This new technology will standardize and simplify very complex anastomosis procedures. We believe it is an important step towards improving procedural efficiencies in microsurgical procedure applications.
• In June 2022, Johnson & Johnson launched the ECHELON 3000 Stapler in the US. The stapler is digitized and focused on surgical control and precision. J&J's current and ongoing developments in surgical technology are required to allow new innovations to the market, which will potentially improve patient outcomes.
• In December 2018, Medtronic completed the acquisition of Mazor Robotics. This acquisition will enhance its robotic-assisted surgery solutions. Medtronic can enhance Mazor's robotic systems with its spinal surgery technologies. The acquisition strengthens Medtronic's market position in two very large markets for anastomotic and surgical devices.